Industry Trends

Loading...

Clinical Research
Off-shoring: A Country Attractiveness Index for Clinical Trials

By Mark P. Mathieu
For many years, pharmaceutical companies have been off-shoring manufacturing operations to lower-cost countries. Healthy margins and strong risk aversion have afforded pharmaceutical companies the luxury of staying close to home, for all but manufacturing activities. As financial pressures increase, pharmaceutical executives are finding that going offshore is not only less risky than it once was, but also too attractive to ignore.  Read More



Site Solutions for All that Ails EDC



Loading...

By Deb Borfitz

June 22, 2009 | In a recent issue of eCliniqua, investigative sites aired their frustrations with many of the e-clinical technologies embraced by study sponsors. They made particular note of technical deficiencies with electronic data capture (EDC) systems. But, as discussed below, they also offered some solid remedies for improving the situation.

Sponsors building electronic case report forms (eCRFs) in-house might want to start pre-populating data fields with information from subjects’ prior visits, says Diane Palmer, site administrator and clinical research coordinator at New London, Conn.-based Coastal Connecticut Research (CCR). Better yet, site personnel could enter study visit data on a single page.

The Holy Grail of eCRFs would be for the industry as a whole to come up with standards for data entry, she continues. For sites like CCR doing multiple studies, it’s difficult to remember company-specific requirements for inputting information. There are four alternatives for the date format alone: 5/26/2009, 26May2009, 26May09, or 5/26/09. Failure to follow data-entry rules results in automatically generated, time-consuming queries, which steals time from patient recruitment activities.

Palmer declares Phase Forward’s Inform EDC system “one of the best” and worthy of mimicking, including its online training module that includes a printed certificate of completion. Unfortunately, she adds, companies rarely accept the certificate as proof of training for subsequent studies using the same system. She can complete the online test in ten minutes because she knows the answers by heart. Ironically, being a speedy test-taker flags her as a potential cheater in the eyes of some sponsors.

EDC systems as a rule fail to provide the kind of information that could make life easier for sites, such as a study’s enrollment status, according to Richard Litov, director of Pedia Research in Owensboro, KY. Instead, they deliver the intelligence six weeks late via hardcopy newsletters. “Sponsors and CROs can see that information [electronically]. Why not us too?”

Similarly, adds Litov, central lab vendors continue to transmit lab values via fax. In an ideal world, sites would receive lab reports electronically, including a graphic display comparing current and previous lab values of a study subject so investigators don’t have to sift through paper charts to detect important changes. Doing so “would lead to better oversight and evaluation of safety.”

Litov says it would serve sponsors’ interests to involve at least a few sites in the technology acquisition process and then conduct post-study surveys to learn how well a chosen EDC system performs in the real world. “We’ve seen a sponsor switch to a different EDC system for each of three studies conducted in the same program.”

From the standpoint of consistency and accuracy, it would be advantageous for sponsors to provide a standard, study-specific template for source document forms rather than rely on each site to generate their own forms from scratch, especially since these forms mirror the CRFs that are already produced, says Litov. He estimates that Pedia Research donates between 5-20 hours of “secretarial work” per study to create the requisite forms. “Multiply that by 50 or more sites for a multi-center trial and that is a lot of wasted time diverting sites from starting up a study.”

Kelly Walker, chief operating officer at Research Across America (RAA) in Dallas, believes it is time EDC systems were incorporating user-friendly handwriting or voice recognition features. Knowing it could be a long wait, he has taken matters into his own hands by developing a single-data-entry system called DB Pharma, with a programmer familiar with Microsoft tools.

DB Pharma, run off a wireless tablet, utilizes handwriting recognition technology and immediately transmits data to a web host. But it only gets used on a few studies a year, when RAA is responsible for either all of the data capture or all of the data analysis. The system’s only downside, Walker says, is that it doesn’t accommodate doctors’ notoriously sloppy script.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

sas_f0910
Rethinking Clinical Trials Data Integration
Sponsored by SAS

There is a gap between the need for data integration and fully integrated systems. To find out why, SAS and Pharmaceutical Executive conducted confidential telephone interviews with senior pharmaceutical executives and CROs. This article discusses recommendations on how to achieve optimal clinical data integration, based on those interviews.



ClearTrial_BriefingOn
eClinical Trial Technologies Revolutionizing Clinical Development Efficiency
Sponsored by ClearTrial
This Bio-IT World BriefingON report, sponsored by ClearTrial, presents a selection of recent stories from Bio•IT World and sister publication, eCliniqua, that illustrate how new technologies and approaches can have a profound impact on the management and execution of clinical trials.


oracle_RDC
Remote Data Capture:Acquisition and Analysis
Sponsored by Oracle

See why Electronic Data Capture (EDC) is gaining traction in the pharmaceutical
clinical trials arena. Today approximately half of all clinical trials are conducted
electronically, and the figure is rapidly rising. Report includes contributions from
Oracle Health Sciences, Pfizer, PPD, and C3i.

 



Life Science Webcasts & Podcasts

Bio-IT World & CHI

Impact of the 1000 Genomes Project on the Next Wave of Pharmacogenomic Discovery
1000genomeInterview with M. Eileen Dolan, Ph.D., Professor, Medicine, University of Chicago and Speaker at Next-Generation Sequencing Data Management, September 27-29, 2010, Providence, RI  

The 1000 Genomes Project aims to provide detailed genetic variation data on >1000 genomes from worldwide populations using the next-generation sequencing technologies. Some of the samples utilized for the 1000 Genomes Project are the International Hap-Map samples that are composed of lymphoblastoid cell lines (LCLs) derived from individuals of different world populations. The detailed map of human genetic variation promised by the 1000 Genomes project will allow a more in-depth analysis of the contribution of genetic variation to drug response. Future studies utilizing this new resource can greatly enhance our understanding of the genetic basis of drug response and other complex traits.


Download Now 



More Podcasts

Job Openings

mskc logo
Software Engineer – Computational Biology Center

Memorial Sloan-Kettering Cancer Center seeks an Engineer to design and develop complex data analysis systems in support of cancer genomics research projects at the Computational Biology Center. Qualified candidate will have a BA, 5+ years of software development experience and expert knowledge of Java, SQL, and HTML.

Apply: www.mskcciscareers.org.  Equal opportunity and affirmative action employer.

Loading...

For reprints and/or copyright permission, please contact The YGS Group, 3650 West Market Street, York, PA;

(717) 505-9701 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.